{ }
001122334455554433221100
001122334455554433221100

Boston Scientific Leads Medical AI Stocks Amid Growing Investor Interest

Boston Scientific Corp (BSX) is gaining attention as part of the rapidly evolving medical AI sector, which is projected to grow from $11 billion to $188 billion by 2030. The integration of AI in healthcare is enhancing early disease detection, drug discovery, and patient outcomes, driving significant investor interest. As companies like Mayo Clinic leverage AI for improved cancer care and operational efficiency, the potential for innovation in this space continues to attract hedge fund investments.

Top Health Care Stocks to Consider for Investment in 2025

Amgen's MariTide obesity drug showed mid-stage trial results in line with competitors, while Stryker's Mako robotic product and outpatient focus position it as a strong investment. Pfizer's potential divestment of its hospital drugs business could enhance its core growth, and Boston Scientific's promising pipeline supports its long-term outlook. CFRA maintains "buy" ratings for these companies, with specific price targets reflecting their growth potential.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Machinary - Dashboard

Client connection lost

Please check your connection. We try to reconnect...

Server connection lost

If our server is updating to a new version, please wait a moment before the service is available again.

Connection refused

All connection attempts have been rejected. This is most likely due to network problems or server problems.